-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QMeSR7j2i129AQbomAoAxLWUp1zpRAtIT3NpBicFUO8SgjBlxeD+//b5vNWxLwTA bo9RupTHDoB3aPB67GQYzA== 0001127602-11-008513.txt : 20110302 0001127602-11-008513.hdr.sgml : 20110302 20110302173151 ACCESSION NUMBER: 0001127602-11-008513 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110301 FILED AS OF DATE: 20110302 DATE AS OF CHANGE: 20110302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SULLIVAN LOUIS W CENTRAL INDEX KEY: 0001193522 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 11657527 FORMER NAME: FORMER CONFORMED NAME: SULLIVAN LOUIS DATE OF NAME CHANGE: 20020927 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2011-03-01 0001082554 UNITED THERAPEUTICS Corp UTHR 0001193522 SULLIVAN LOUIS W C/O UNITED THERAPEUTICS CORPORATION 1040 SPRING STREET SILVER SPRING MD 20910 1 Common Stock 2011-03-01 2011-03-01 4 M 0 6000 24.39 A 6000 D Common Stock 2011-03-01 2011-03-01 4 S 0 6000 67.3885 D 0 D Stock Options 24.39 2011-03-01 2011-03-01 4 M 0 6000 0 D 2006-06-29 2015-06-29 Common Stock 6000 18000 D Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009. This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. /s/ John S. Hess, Jr. under Power of Attorney 2011-03-02 -----END PRIVACY-ENHANCED MESSAGE-----